Loading patent…
AssigneesUbe Industries, Ltd., Santen Pharmaceuticals Co., Ltd.
InventorsMasahiko Hagihara, Ken-ichi Komori, Hidetoshi Sunamoto, Hiroshi Nishida, Takeshi Matsugi, Tadashi Nakajima, Masakazu Hatano, Kazutaka Kido, Hideaki Hara
Estimating the term…
A method for treating a disease in which Rho kinase is involved. The method is carried out by administering to a patient in need thereof a pharmaceutically effective amount of a compound of the following formula or a pharmaceutically acceptable salt thereof: , wherein the ring X is a benzene ring or a pyridine ring; R1 and R2 are hydrogen or alkyl or together form a cycloalkene ring; R3 is hydrogen, substituted alkyl, unsubstituted alkenyl, carboxyl or an ester or an amide thereof, amino or a cyano; R4 is hydrogen, hydroxyl, substituted or unsubstituted alkoxy, unsubstituted alkenyloxy, unsubstituted cycloalkyloxy, substituted or unsubstituted alkyl, unsubstituted alkenyl, unsubstituted cycloalkyl, amino, substituted or unsubstituted alkylamino, nitro, cyano or a monocyclic heterocycle; and R5 is a halogen atom or a hydrogen atom.
A method for treating a disease in which Rho kinase is involved comprising administering to a patient in need thereof a pharmaceutically effective amount of a compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof:
A method for treating a disease in which Rho kinase is involved comprising administering to a patient in need thereof a pharmaceutically effective amount of a compound selected from the group consisting of
Dependencies are inferred from the claim text.